Annual Drug Patent Expirations for PYLARIFY
Pylarify is a drug marketed by Progenics Pharms Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has seventy-four patent family members in twenty-three countries.
The generic ingredient in PYLARIFY is piflufolastat f-18. One supplier is listed for this compound. Additional details are available on the piflufolastat f-18 profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
